Science Explorer Interactive view Map
Company · Unterföhring · Germany

Omnicare Pharma (Germany)

omnicare.deROR OpenAlex
Research works
58
▼ 63% vs 2013–17
Citations
593
10.3 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
14%
world 28%

Not ranked overall: Omnicare Pharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Immunology and Microbiology: 9.75× its world share, 0 worksImmunology and Micro…Neuroscience: 3.02× its world share, 0 worksNeuroscienceEngineering: 0.16× its world share, 0 worksEngineeringPhysics and Astronomy: 1.10× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.66× its world share, 0 worksHealth ProfessionsMedicine: 3.64× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 0.51× its world share, 0 worksEconomics, Econometr…Psychology: 1.61× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.8×. Every wedge is a field page.

Which keywords describe research at Omnicare Pharma (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Cardiovascular Disease, Epidemiology, Heart Failure, Inflammation, Aging, Clinical Trials and Elderly.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology6▲ 2.7×15 topics
  2. Quality of Life5▲ 6.1×10 topics
  3. Cardiovascular Disease4▲ 6.8×11 topics
  4. Inflammation4▲ 3.2×10 topics
  5. Heart Failure3▲ 12×7 topics
  6. Aging3▲ 9.2×4 topics
  7. Clinical Trials3▲ 7.3×8 topics
  8. Diabetes2▲ 8.3×6 topics
  9. Diagnosis2▲ 4.2×5 topics
  10. Elderly2▲ 18×4 topics
  11. Chronic Kidney Disease2▲ 17×7 topics
  12. Glycemic Control2▲ 26×4 topics
  13. Nursing Home2▲ 94×1 topic
  14. Quality of Care2▲ 46×1 topic
  15. Clinical Practice Guidelines2▲ 6.0×4 topics
  16. Primary Care2▲ 7.3×4 topics
  17. Clinical Guidelines2▲ 9.3×3 topics
  18. Cost-effectiveness Analysis2▲ 38×1 topic
  19. Health Utility Measures2▲ 38×1 topic
  20. Healthcare-Associated Infections2▲ 24×4 topics
  21. Inappropriate Medication Use2▲ 71×1 topic
  22. Insulin Therapy2▲ 25×3 topics
  23. Polypharmacy2▲ 71×1 topic
  24. Elderly Patients2▲ 20×4 topics
  25. Global Burden1▲ 4.5×3 topics
  26. Gastrointestinal Disorders1▲ 38×2 topics
  27. Health Information Management1▲ 135×2 topics
  28. Immune System1▲ 7.1×2 topics
  29. Neuropathology1▲ 27×2 topics
  30. Probiotics1▲ 9.3×2 topics
  31. Cancer Cachexia1▲ 36×1 topic
  32. Patient Safety1▲ 17×2 topics
  33. Sarcopenia1▲ 36×1 topic
  34. Prevention Strategies1▲ 20×2 topics
  35. Urinary Incontinence1▲ 21×2 topics
  36. Wavelet Transform1▲ 9.6×3 topics
  37. Cardiovascular Outcomes1▲ 42×1 topic
  38. Drug Development1▲ 13×2 topics
  39. Mortality Risk1▲ 8.7×2 topics
  40. Type 2 Diabetes1▲ 9.5×1 topic

Which research topics does Omnicare Pharma (Germany) publish most on?

By volume in 2022–2025: Cannabis and Cannabinoid Research, Biosimilars and Bioanalytical Methods, Biomedical Ethics and Regulation and CAR-T cell therapy research.

Cannabis and Cannabinoid…0Cannabis and Cannabinoid Research: 0 fractional worksBiosimilars and Bioanaly…0Biosimilars and Bioanalytical Methods: 0 fractional worksBiomedical Ethics and Re…0Biomedical Ethics and Regulation: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksHeart Failure Treatment and Management: 0 fractional worksSleep and Wakefulness Research: 0 fractional worksSleep and related disord…0Sleep and related disorders: 0 fractional worksPulmonary Hypertension Research and Treatments: 0 fractional worksCardiovascular and exercise physiology: 0 fractional worksMobile Health and mHealth Applications: 0 fractional works
PharmacologyImmunologyPhysiologyOncology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cannabis and Cannabinoid Research Pharmacology 0 works
  2. 2 Biosimilars and Bioanalytical Methods Immunology 0 works
  3. 3 Biomedical Ethics and Regulation Physiology 0 works
  4. 4 CAR-T cell therapy research Oncology 0 works
  5. 5 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 0 works
  6. 6 Sleep and Wakefulness Research Cognitive Neuroscience 0 works
  7. 7 Sleep and related disorders Experimental and Cognitive Psychology 0 works
  8. 8 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 0 works
  9. 9 Cardiovascular and exercise physiology Complementary and alternative medicine 0 works
  10. 10 Mobile Health and mHealth Applications General Health Professions 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available14.5%not open85.5%

World: 28% of research is openly available.

with international co-authors28.3%domestic only71.7%

World: 19% is written across borders.

How has Omnicare Pharma (Germany)'s research output changed?

Output in 2018–2022 was 63% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.